December 11, 2012
Drugmaker Eli Lilly & Co. sued the U.S. Patent and Trademark Office in Virginia federal court Tuesday, claiming the agency acted arbitrarily in failing to extend its patent for a cancer treatment solution and methods by an additional year and a half.